Citra Borneo Utama Tbk. vs Kalbe Farma Tbk — how do they compare? Citra Borneo Utama Tbk. trades at Rp790 (market cap 2.48T, 18.1K 24h volume), while Kalbe Farma Tbk trades at Rp715 (market cap 33T, 30.22M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 13.3× Citra Borneo Utama Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (30.22M versus 18.1K). Which is the better fit depends on your goals.
| CBUT | KLBF | |
|---|---|---|
Market Cap | 2.48T | 33T |
Volume | 18.1K | 30.22M |
Lot | 181 | 302.24K |
Turnover | 14.42M | 21.57B |
Average Price | 796.8 | 713.72 |
Value | 14.42M | 21.57B |
Indicative Equilibrium Price | 810 | 705 |
Indicative Equilibrium Volume | 24 | 1M |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →